idiopathic pulmonary fibrosis

First AI-discovered drug enters Phase III trial

Insilico Medicine announced on Tuesday that it dosed the first patient with Rentosertib in GENESIS-IPF-3, marking the first time a drug candidate discovered and designed entirely by generative AI has entered a Phase III clinical trial. The dosing took place…

You're all caught up

You've seen all the main stories from the past 2 days.